Hardy Reed
BMY icon

Hardy Reed’s Bristol-Myers Squibb BMY Stock Holding History

Hardy Reed’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$849K Buy
13,599
+4,910
+57% +$310K 0.05% 114
2026
Q2 		$501K Buy
8,689
+343
+4% +$19.7K 0.03% 153
2026
Q1 		$506K Buy
8,346
+269
+3% +$15.7K 0.04% 141
2025
Q4 		$436K Buy
8,077
+263
+3% +$12.7K 0.03% 153
2025
Q3 		$352K Buy
7,814
+1,125
+17% +$52.5K 0.03% 179
2025
Q2 		$310K Buy
6,689
+61
+0.9% +$2.99K 0.02% 181
2025
Q1 		$404K Buy
6,628
+123
+2% +$7.17K 0.04% 149
2024
Q4 		$368K Buy
6,505
+70
+1% +$3.91K 0.03% 161
2024
Q3 		$333K Buy
6,435
+105
+2% +$4.93K 0.03% 173
2024
Q2 		$263K Buy
+6,330
New +$283K 0.03% 200

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Hardy Reed's BMY Position: Q3 2026 in Review

Hardy Reed increased its Bristol-Myers Squibb (BMY) stake by 57% in Q3 2026, buying an estimated $310K and bringing the position to 13,599 shares worth $849K. The position accounts for 0.05% of the portfolio, ranked #114.

Hardy Reed first reported a position in BMY in Q2 2024 and has held it in 10 quarters since. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Hardy Reed held 13,599 shares of Bristol-Myers Squibb worth $849K as of Q3 2026.
  • Hardy Reed bought 4,910 Bristol-Myers Squibb shares in Q3 2026, an estimated $310K.
  • Bristol-Myers Squibb made up 0.05% of Hardy Reed's portfolio in Q3 2026, its #114 holding.
  • Hardy Reed first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 10 quarters since.
  • 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Hardy Reed's 13F filing for Q3 2026, filed 6 Nov 2026.